Enzymatica AB Sustainability Reports
Enzymatica AB develops and sells medical devices that fight viruses and microorganisms to protect the body against upper respiratory tract infections. Its flagship product is ColdZyme, a mouth spray designed to treat and alleviate common cold symptoms.
Sector: Wholesale & retail
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 529900HNJP0335URJQ76
FIGI: BBG001V0CWB6
6 reports from 2013 to 2025
